Clinical Trials on Vascular Health
Total 97108 results
-
University of BurgundyAssociation pour le Développement de la Recherche en Médecine Générale (ADRMG) and other collaboratorsUnknownHypertension | Primary Health Care | Blood Pressure Monitoring, AmbulatoryFrance
-
Vastra Gotaland RegionSwedish Heart Lung FoundationRecruitingHypertension | Primary Health Care | Drug TherapySweden
-
Codman & ShurtleffCompletedIntracranial, Wide-Neck, Saccular Aneurysms
-
National Institutes of Health Clinical Center (CC)RecruitingHealthy Volunteers | Endothelial Dysfunction | Inflammation in Cardiopulmonary and Vascular Disease StatesUnited States
-
Yonsei UniversityNot yet recruitingHealth Status(Death, Stroke Etc)Korea, Republic of
-
Texas Tech UniversityMcCormick and Company, Inc.Active, not recruitingHypertension | Diet, Healthy | Culinary MedicineUnited States
-
KU LeuvenResearch Foundation FlandersCompleted
-
University of Erlangen-Nürnberg Medical SchoolCompletedArterial Hypertension | Healthy IndividualsGermany
-
Neurotech PharmaceuticalsNot yet recruitingMacular Telangiectasia Type 2United States
-
Rajavithi HospitalCompletedSymtomatic Macular Polypoidal Choroidal VasculopathyThailand
-
Stanford UniversityCompletedPhysical Activity | Health Behavior | Dietary Modification | Attitude to Health | Vascular; ChangeUnited States
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Neurotech PharmaceuticalsThe Emmes Company, LLC; The Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Aier School of Ophthalmology, Central South UniversityUnknownWet Macular DegenerationChina
-
The Lowy Medical Research Institute LimitedActive, not recruitingMacular Telangiectasia Type 2United States, United Kingdom
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Atherosclerosis | Vascular DiseaseUnited States
-
MidAtlantic RetinaUnknownAge-related Macular Degeneration | Retina Vein Occlusion | Diabetic Vascular Diseases | Proliferative RetinopathyUnited States
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting
-
French Cardiology SocietyCompletedHealthy Volunteers | Essential Untreated HypertensionFrance
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedBlood Flow in Healthy VolunteersNetherlands
-
The Cleveland ClinicCompletedCoronary Artery Diseases | Valvular Heart DiseasesUnited States
-
University of AthensCompletedRetinal Vein Occlusion | Vascular Occlusive Disease
-
National University of SingaporeCompletedHealth Behavior | Health Knowledge, Attitudes, Practice | CHD - Coronary Heart Disease
-
Tulane UniversityNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingHypertension | Patient Engagement | Health Behavior | Adherence, Patient | Healthcare Patient Acceptance
-
Northwell HealthWithdrawn
-
Brigham and Women's HospitalMassachusetts Institute of TechnologyCompletedHealthy | Compartment Syndrome of LegUnited States
-
Northumbria UniversityRecruitingPeripheral Arterial Disease | Intermittent Claudication | Behavior, Health | Exercise InterventionUnited Kingdom
-
Perosphere Pharmaceuticals Inc, a wholly owned...Quintiles, Inc.Completed
-
GlaxoSmithKlineCompletedAtherosclerosis | Healthy SubjectsAustralia
-
National Eye Institute (NEI)CompletedMacular TelangiectasiaUnited States
-
The Hong Kong Polytechnic UniversityNot yet recruitingCardiovascular Diseases | Health Education | Healthy LifestyleHong Kong
-
The Hong Kong Polytechnic UniversityNot yet recruitingCardiovascular Diseases | Health Education | Healthy Lifestyle
-
Perosphere Pharmaceuticals Inc, a wholly owned...Quintiles, Inc.Completed
-
Regional Hospital HolstebroCompletedHealthy | White Coat Hypertension | Essential HypertensionDenmark
-
University Hospital, RouenInstitut National de la Santé Et de la Recherche Médicale, FranceUnknownHealthy | Aging | Vascular StiffnessFrance
-
I.M. Sechenov First Moscow State Medical UniversityCompletedSurgery | Valvular Heart Disease | Aortic Arch AneurysmRussian Federation
-
Niguarda HospitalCompletedHealth Subjects With Cardiovascular Risk FactorsItaly
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Hypertension | Heart Arrest | Death, Sudden, Cardiac
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Healthy | AtherosclerosisUnited States
-
French Cardiology SocietyFrench Federation of CardiologyCompleted
-
Salutaris Medical Devices, Inc.Not yet recruitingAge-Related Macular Degeneration | Polypoid Choroidal Vasculopathy
-
Foundation for Science, Health and Education, SpainHospital del Mar Research Institute (IMIM); La Caixa FoundationEnrolling by invitationHealth Behavior | Healthy Lifestyle | Heart Disease Risk FactorsSpain
-
Rutgers, The State University of New JerseyNational Center for Advancing Translational Sciences (NCATS)CompletedHypertension | Health Knowledge, Attitudes, Practice | Adolescent BehaviorUnited States
-
Regional Hospital HolstebroCompletedEssential Hypertension and Healthy ControlsDenmark
-
Singapore National Eye CentreBayerCompletedAge Related Macular Degeneration | Polypoidal Choroidal VasculopathySingapore
-
Navy General Hospital, BeijingNot yet recruitingVenous Thromboembolism | Clinical Decision Support Systems | Digital Health
-
Mayo ClinicCompletedVenous Thromboembolism | Quality Improvement | Delivery of Health CareUnited States
-
Pusan National University HospitalBayerCompletedPolypoidal Choroidal Vasculopathy | Exudative Age-related Macular DegenerationKorea, Republic of